Bavarian Nordic A/S (OTCMKTS:BVNRY) Stock Crosses Below Two Hundred Day Moving Average of $7.60

Bavarian Nordic A/S (OTCMKTS:BVNRY)’s stock price crossed below its two hundred day moving average during trading on Wednesday . The stock has a two hundred day moving average of $7.60 and traded as low as $7.02. Bavarian Nordic A/S shares last traded at $7.03, with a volume of 722 shares traded.

Bavarian Nordic A/S Stock Performance

The stock has a 50-day moving average of $7.66 and a two-hundred day moving average of $7.60. The company has a market cap of $1.65 billion, a P/E ratio of 7.40 and a beta of 1.50.

Bavarian Nordic A/S (OTCMKTS:BVNRY) last announced its quarterly earnings data on Wednesday, March 6th. The company reported $0.56 earnings per share for the quarter, beating the consensus estimate of $0.44 by $0.12. Bavarian Nordic A/S had a return on equity of 0.07% and a net margin of 20.80%. The firm had revenue of $353.27 million during the quarter, compared to the consensus estimate of $340.71 million. As a group, sell-side analysts forecast that Bavarian Nordic A/S will post 0.57 EPS for the current fiscal year.

Bavarian Nordic A/S Company Profile

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.